Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling. Sajjadi E, Venetis K, Piciotti R, Gambini D, et al. BMC Cancer 2021;21:1152.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sajjadi E, Venetis K, Piciotti R, Gambini D, et al. Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling. BMC Cancer 2021;21:1152.
PMID: 34706703